Literature DB >> 16841252

Prooxidant action of xanthurenic acid and quinoline compounds: role of transition metals in the generation of reactive oxygen species and enhanced formation of 8-hydroxy-2'-deoxyguanosine in DNA.

Keiko Murakami1, Miyako Haneda, Masataka Yoshino.   

Abstract

Xanthurenic acid, a product of tryptophan-NAD pathway, and quinoline compounds produced reactive oxygen species as a complex with iron. Aconitase, the most sensitive enzyme to oxidative stress was inactivated effectively by xanthurenic acid and to a lesser extent by 8-quinolinol in the presence of ferrous sulfate. The inactivation of aconitase was iron-dependent, and was prevented by TEMPOL, a scavenger of reactive oxygen species, suggesting that reduced iron bound to xanthurenic acid or 8-quinolinol can activate oxygen molecule to form superoxide radical. However, kynurenic acid and quinaldic acid without 8-hydroxyl group did not produce reactive oxygen species. Of the quinoline compounds tested, xanthurenic acid and 8-quinolinol with 8-hydroxyl group stimulated the autooxidation of ferrous ion, but kynurenic acid and quinaldic acid did not affect the oxidation of ferrous ion. Hydroxyl group at 8-positions of quinoline compounds was essential for the binding of iron causing the generation of reactive oxygen species. 8-Quinolinol effectively enhanced the ascorbate/copper-mediated formation of 8-hydroxy-2'-deoxyguanosine in DNA, suggesting the quinolinol/copper-dependent stimulation hydroxyl radical formation. Xanthurenic acid and 8-quinolinol as the metal-chelate complexes can show various cytotoxic effects by generating reactive oxygen species through the ferrous or cuprous ion-dependent activation of oxygen molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16841252     DOI: 10.1007/s10534-005-4528-6

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  9 in total

Review 1.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

Review 2.  Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.

Authors:  Qiongxin Wang; Danxia Liu; Ping Song; Ming-Hui Zou
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

Review 3.  Redox Properties of Tryptophan Metabolism and the Concept of Tryptophan Use in Pregnancy.

Authors:  Kang Xu; Hongnan Liu; Miaomiao Bai; Jing Gao; Xin Wu; Yulong Yin
Journal:  Int J Mol Sci       Date:  2017-07-24       Impact factor: 5.923

4.  Antioxidant Properties and the Formation of Iron Coordination Complexes of 8-Hydroxyquinoline.

Authors:  Vladimir Chobot; Franz Hadacek; Gert Bachmann; Wolfram Weckwerth; Lenka Kubicova
Journal:  Int J Mol Sci       Date:  2018-12-07       Impact factor: 5.923

5.  Coordination Complex Formation and Redox Properties of Kynurenic and Xanthurenic Acid Can Affect Brain Tissue Homeodynamics.

Authors:  Lenka Kubicova; Franz Hadacek; Gert Bachmann; Wolfram Weckwerth; Vladimir Chobot
Journal:  Antioxidants (Basel)       Date:  2019-10-11

6.  Generation of reactive oxygen species by hydroxypyridone compound/iron complexes.

Authors:  Keiko Murakami; Masataka Yoshino
Journal:  Redox Rep       Date:  2020-12       Impact factor: 4.412

7.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

Review 8.  Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases.

Authors:  Jazmin Reyes Ocampo; Rafael Lugo Huitrón; Dinora González-Esquivel; Perla Ugalde-Muñiz; Anabel Jiménez-Anguiano; Benjamín Pineda; José Pedraza-Chaverri; Camilo Ríos; Verónica Pérez de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2014-02-17       Impact factor: 6.543

9.  Possible Use of Blood Tryptophan Metabolites as Biomarkers for Coronary Heart Disease in Sudden Unexpected Death.

Authors:  Kobchai Santisukwongchote; Yutti Amornlertwatana; Thanapat Sastraruji; Churdsak Jaikang
Journal:  Metabolites       Date:  2019-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.